Onyx Biotec Limited — Board Meeting, 28-05-2025: Outcome of Board Meeting

Onyx Biotec has announced a board meeting outcome approving the financial results for the quarter and half-year. Revenue climbed to ₹61.95 Cr, with net profit jumping to ₹4.95 Cr from ₹3.63 Cr year-on-year. The company showcased strong operational cash flow and reduced its borrowings, boosting reserves significantly. Utilization of IPO funds remains on track, with ₹17.89 Cr directed towards loan repayment and corporate expenses, while ₹7.31 Cr is secured in fixed deposits. The audit report came through clean, reflecting solid financial health.